Cardinal Health, Inc. (CAH) Análisis de acciones

Descripción de la empresa

Cardinal Health, Inc. operates as a comprehensive provider of healthcare services and products, serving customers across the United States and international markets through specialized distribution segments. The company functions within the Healthcare sector, specifically the Medical Distribution industry, facilitating the flow of essential medical supplies to hospitals and healthcare institutions. Its operational scale is significant, with a market capitalization of $48.61B and an annual revenue (TTM) of $244.67B, supported by a workforce of 53,084 employees. These valuation and revenue figures indicate that Cardinal Health holds a substantial position in the market, reflecting its role as a major player in the medical distribution landscape with a broad reach and established infrastructure.

Salud financiera

The company reported a revenue of $244.67B (TTM) alongside a net income of $1.66B and an EBITDA of $3.82B, revealing a cost structure where operating expenses consume the majority of gross sales. The substantial gap between the $244.67B revenue and the $1.66B net income highlights the thin profit margins inherent in the distribution business model, where high volume is necessary to generate absolute earnings. Free cash flow stands at $5.44B, which provides the company with significant financial flexibility to fund operations, service debt, or pursue strategic initiatives without relying heavily on external financing. The margin profile consists of a Gross Margin of 3.7%, an Operating Margin of 1.2%, and a Profit Margin of 0.7%, all of which indicate a low-margin business where operational efficiency is critical for profitability. On the balance sheet, the company holds $2.78B in cash against $9.03B in debt, and while the Debt to Equity ratio is listed as N/A, the absolute debt figure relative to cash suggests a leveraged position that requires steady cash flow management. The Current Ratio is 0.91, indicating that current liabilities slightly exceed current assets, which points to a need for careful management of short-term liquidity to meet upcoming obligations. Return on Equity is listed as N/A, whereas Return on Assets is 3.5%, a metric that reveals management's effectiveness in utilizing the company's asset base to generate earnings relative to the total assets employed.

Evaluación de valoración

The trailing twelve-month P/E Ratio is 29.77, while the Forward P/E is 17.84, implying that the market expects a significant increase in earnings per share in the future to justify the current price or that the stock is priced based on lower current earnings expectations. The Price to Book ratio is -16.91, a negative figure that indicates the market values the company below its book value, often seen in mature distribution companies with heavy asset bases or specific accounting treatments for goodwill. The Price to Sales ratio of 0.20 and an EV/EBITDA of 14.40 suggest that the stock is valued on a revenue basis that is quite low relative to total sales, while the EV/EBITDA provides a multiple based on operational earnings that is moderate for the industry. The 52-week trading range spans from a low of $120.72 to a high of $233.60, meaning the current price context must be evaluated against this wide historical band to understand recent volatility. With a Beta of 0.62, the stock exhibits lower price volatility relative to the broader market, suggesting it may be less sensitive to general market fluctuations compared to the overall index.

Growth & Income

Revenue growth (YoY) is 18.8% and earnings growth (YoY) is 19.4%, indicating that earnings are expanding at a slightly faster pace than revenue, which implies improvements in operational efficiency or margin expansion despite the low absolute profit margins. As a dividend payer, the company offers a Dividend Yield of 1.0% with a Payout Ratio of 29.3%, a low percentage that suggests the dividend is highly sustainable given the company's earnings and cash flow generation capabilities. The low payout ratio indicates that Cardinal Health retains a majority of its earnings, allowing for reinvestment into growth initiatives rather than distributing all profits to shareholders. Overall, the growth and income profile combines moderate dividend income with double-digit revenue and earnings expansion, positioning the company as a stable yet growing entity within the healthcare distribution sector.